director buys27 Oct 2016 11:50
The chairman has been receiving shares from Feb this year so not a great record ! Some newbies probably don't understand the bio industry but they are a money pit and it generally takes something transformational to lift them out of the doldrums. This has been going for over 20 years but I don't see anything on the horizon to give the sp the hoped for bounce.
10 years is nothing for a trial and that's if it is successful. There is also the competition who may beat you to market with a similar product. Oxb trials are all early stage. For the risk of repeating myself the only upside I see in the short to medium term is the manufacturing side. Details are a tad scant at the moment but as results are released we may see an uplift if it can offset the cost of trials.
There is going to be a fundraising and further dilution year on year so we may just get used to it. Short or long, made me chuckle. Bless..